JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, cilt.29, sa.19, ss.3193-3197, 2016 (SCI-Expanded)
Objective: To evaluate the circulating soluble fms-like tyrosine kinase 1 (sFlt1), placental growth factor (PlGF) and vascular endothelial growth factor (VEGF) levels in women with abnormal placentation and to compare the data with the results of women with normal pregnancy.